These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 14644337)

  • 1. The impact of new technologies on human population studies.
    Waters MD; Selkirk JK; Olden K
    Mutat Res; 2003 Nov; 544(2-3):349-60. PubMed ID: 14644337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenomic approach for assessing toxicant-related disease.
    Waters MD; Olden K; Tennant RW
    Mutat Res; 2003 Nov; 544(2-3):415-24. PubMed ID: 14644344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating mechanistic and polymorphism data to characterize human genetic susceptibility for environmental chemical risk assessment in the 21st century.
    Mortensen HM; Euling SY
    Toxicol Appl Pharmacol; 2013 Sep; 271(3):395-404. PubMed ID: 21291902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base.
    Waters M; Boorman G; Bushel P; Cunningham M; Irwin R; Merrick A; Olden K; Paules R; Selkirk J; Stasiewicz S; Weis B; Van Houten B; Walker N; Tennant R
    EHP Toxicogenomics; 2003 Jan; 111(1T):15-28. PubMed ID: 12735106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related disparities: influence of environmental factors.
    Olden K; White SL
    Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to advancing quantitative human health risk assessment of environmental chemicals in the post-genomic era.
    Chiu WA; Euling SY; Scott CS; Subramaniam RP
    Toxicol Appl Pharmacol; 2013 Sep; 271(3):309-23. PubMed ID: 20353796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of biomarkers in monitoring exposures to chemicals: present position, future prospects.
    Watson WP; Mutti A
    Biomarkers; 2004; 9(3):211-42. PubMed ID: 15764289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary research: strategies for assessing chemical mixtures to reduce risk of exposure and disease.
    Suk WA; Olden K
    Int J Occup Med Environ Health; 2004; 17(1):103-10. PubMed ID: 15212212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of human exposure modeling activities at the USEPA's National Exposure Research Laboratory.
    Furtaw EJ
    Toxicol Ind Health; 2001 Jun; 17(5-10):302-14. PubMed ID: 12539877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CEECHE: a practical approach for reducing exposures and disease outcomes in Central and Eastern Europe.
    Suk WA
    Rev Environ Health; 2017 Mar; 32(1-2):3-8. PubMed ID: 27837599
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.